Kbc Group Nv Spectrum Pharmaceuticals Inc Transaction History

Kbc Group Nv

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$0.7 - $1.4 $173,307 - $346,614	-247,582 Closed	0 $0
Q1 2022 Feb 14, 2024	BUY	$0.63 - $1.59 $155,976 - $393,655	247,582 New	247,582 $319,000
Q1 2022 May 06, 2022	BUY	$0.63 - $1.59 $155,976 - $393,655	247,582 New	247,582 $319,000
Q4 2020 Feb 10, 2021	SELL	$3.38 - $5.14 $0 - $0	0 Closed	0 $0
Q3 2020 Feb 14, 2022	BUY	$2.99 - $4.9 $0 - $0	0 New	0 $0
Q3 2020 Oct 28, 2020	SELL	$2.99 - $4.9 $178,218 - $292,064	-59,605 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$2.11 - $3.38 $125,766 - $201,464	59,605 New	59,605 $201,000
Q1 2020 May 04, 2020	SELL	$1.83 - $3.45 $122,900 - $231,698	-67,159 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$7.03 - $9.7 $472,127 - $651,442	67,159 New	67,159 $557,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.